Corporate Health Dynamics

Brian discusses the troubling relationship between corporate profit motives and public health, highlighting how the pharmaceutical industry has prioritized pills and procedures over genuine health improvements. He reflects on historical patterns of regulation and acquisition, revealing how the food industry has evolved in tandem with these corporate interests. This conversation sheds light on the systemic issues that contribute to poor health outcomes despite high spending.